BRAF mutations occur in about 8% of human cancers, including melanoma, colorectal cancer, glioma, thyroid cancer, non-small cell lung cancer, cholangiocarcinoma, and several hematological malignancies (20, 21). This evidence concerns the gene BRAF and hematologic disorder.